Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
associated decrease » associated increase (Expand Search), associated disease (Expand Search), associated diseases (Expand Search)
Showing 1,821 - 1,840 results of 21,342 for search '(( significant decrease decrease ) OR ( significantly associated decrease ))', query time: 0.47s Refine Results
  1. 1821
    Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1.

    Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1. by Mucahit Gemici (21519313)

    Published 2025
    Save to List
    Saved in:
  2. 1822
    One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2.

    One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. by Mucahit Gemici (21519313)

    Published 2025
    Save to List
    Saved in:
  3. 1823
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1824
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1825
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1826
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1827
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1828
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1829
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1830
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1831
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1832
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1833
    Risk of acquiring SARS-CoV-2 infection in the household (children vs. adults).

    Risk of acquiring SARS-CoV-2 infection in the household (children vs. adults). by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1834
    Correlation and median comparison. ACE2 and TMPRSS2 expression.

    Correlation and median comparison. ACE2 and TMPRSS2 expression. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1835
    Correlation between age and ACE2ACE2 and TMPRSS2 protease expression.

    Correlation between age and ACE2ACE2 and TMPRSS2 protease expression. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1836
    Summary of study participants.

    Summary of study participants. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1837
    Fundamental Characteristics of Participants by PAL.

    Fundamental Characteristics of Participants by PAL. by Haiwei Li (282229)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1838
    Most common symptoms and frequency of appearance among IgG-positive patients.

    Most common symptoms and frequency of appearance among IgG-positive patients. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1839
    Fundamental Characteristics of Participants with and without CVD.

    Fundamental Characteristics of Participants with and without CVD. by Haiwei Li (282229)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1840
    Age difference between patients with negative and positive serologic results in adults(a) and children(b).

    Age difference between patients with negative and positive serologic results in adults(a) and children(b). by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: